NASDAQ:IMAC - Nasdaq - US44967K1043 - Common Stock - Currency: USD
NASDAQ:IMAC (8/5/2022, 8:25:24 PM)
1.01
+0.02 (+2%)
The current stock price of IMAC is 1.01 USD. In the past month the price increased by 2.54%. In the past year, price decreased by -35.67%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 14.3 | 80.15B | ||
BKDT | BROOKDALE SENIOR LIVING - BKD 7 11/15/25 | N/A | 14.59B | ||
THC | TENET HEALTHCARE CORP | 10.89 | 12.32B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 12.12 | 11.88B | ||
EHC | ENCOMPASS HEALTH CORP | 22.02 | 9.83B | ||
ENSG | ENSIGN GROUP INC/THE | 22.97 | 7.26B | ||
ACHC | ACADIA HEALTHCARE CO INC | 11.3 | 3.68B | ||
SGRY | SURGERY PARTNERS INC | 26.93 | 3.22B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 8.6 | 2.92B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 9.02 | 2.28B | ||
PACS | PACS GROUP INC | 16.83 | 1.98B | ||
ARDT | ARDENT HEALTH PARTNERS INC | 36.58 | 1.98B |
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.
IMAC HOLDINGS INC
1605 Westgate Cir
Brentwood TENNESSEE 37027 US
CEO: Jeffrey S. Ervin
Employees: 154
Company Website: https://imacregeneration.com/
Phone: 18442664622.0
The current stock price of IMAC is 1.01 USD. The price increased by 2% in the last trading session.
The exchange symbol of IMAC HOLDINGS INC is IMAC and it is listed on the Nasdaq exchange.
IMAC stock is listed on the Nasdaq exchange.
8 analysts have analysed IMAC and the average price target is 3.59 USD. This implies a price increase of 255.15% is expected in the next year compared to the current price of 1.01. Check the IMAC HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
IMAC HOLDINGS INC (IMAC) has a market capitalization of 26.75M USD. This makes IMAC a Nano Cap stock.
IMAC HOLDINGS INC (IMAC) currently has 154 employees.
IMAC HOLDINGS INC (IMAC) has a support level at 0.99 and a resistance level at 1.04. Check the full technical report for a detailed analysis of IMAC support and resistance levels.
The Revenue of IMAC HOLDINGS INC (IMAC) is expected to grow by 21.45% in the next year. Check the estimates tab for more information on the IMAC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IMAC does not pay a dividend.
IMAC HOLDINGS INC (IMAC) will report earnings on 2022-08-23, before the market open.
IMAC HOLDINGS INC (IMAC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.38).
ChartMill assigns a technical rating of 5 / 10 to IMAC. When comparing the yearly performance of all stocks, IMAC turns out to be only a medium performer in the overall market: it outperformed 43.31% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to IMAC. IMAC may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months IMAC reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 13.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -76.98% | ||
ROA | -48.41% | ||
ROE | N/A | ||
Debt/Equity | 0.01 |
ChartMill assigns a Buy % Consensus number of 80% to IMAC. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 2.98% and a revenue growth 21.45% for IMAC